Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.

STEP perspective - 1 Jan 1995

Bray J M

Abstract excerpt

Research on HIV viral loads and combination therapy was presented at the 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Research has shown that ten billion HIV particles are produced daily in an infected individual's body. The HIV particles live freely for about eight hours before infecting CD4 cells, which live for 2.2 days before dying. The virus replicates in about 1.2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to CD4 Lymphocyte Count
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Didanosine

Share to Drug Therapy, Combination

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Zidovudine

Source

Identifiers

PMID: 11362980

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.PMID 11362980Read ↗

Pharmacological advances in anti‐retroviral therapy for human immunodeficiency virus‐1 infection: A comprehensive reviewSemantic proximity Read ↗

Development of Anti-HIV Therapeutics: From Conventional Drug Discovery to Cutting-Edge TechnologySemantic proximity Read ↗

Antiretroviral Therapy in the ClinicSemantic proximity Read ↗

FDA triple header. Food and Drug Administration.Semantic proximity Read ↗

Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team.Semantic proximity Read ↗

Antiretroviral therapy 2006: pharmacology, applications, and special situations.Semantic proximity Read ↗

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.Semantic proximity Read ↗

Viral load and progression.Semantic proximity Read ↗

Anti-HIV agents. Monotherapy studies--points to consider.Semantic proximity Read ↗

New antiretroviral drugs part I: PIs.Semantic proximity Read ↗

Anti-HIV drug resistance testing.Semantic proximity Read ↗

Cobicistat: Review of a Pharmacokinetic Enhancer for HIV InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.